Chuanxu Liu
Fudan University · Shanghai Cancer Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Chuanxu Liu as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:48 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT07768943 · GELAD-Based Response-Adapted Treatment for Early-Stage Extranodal NK/T-Cell LymphomaFudan University · not yet recruiting · Natural Killer/T-cell Lymphoma · principal investigator
- Ph3NCT07678229 · BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCLRong Tao · recruiting · Extranodal NK/T-cell Lymphoma · principal investigator
- Ph1/Ph2NCT07502768 · Tislelizumab Plus Zeprumetostat for Relapsed or Refractory NK/T-Cell LymphomaRong Tao · recruiting · Extranodal NK/T-cell Lymphoma, NK/T-cell Lymphoma, Relapsed or Refractory NK/T-Cell Lymphoma · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:48 UTC. The ranking covers the 200 most relevant of 2002 PubMed records, and a shared surname and initials can bring in a namesake. All 2002 on PubMed
- 208 citationsRCR 20.3
- A Novel Inflammation and Insulin Resistance Related Indicator to Predict the Survival of Patients With Cancer.Front Endocrinol (Lausanne) · 2022185 citationsRCR 15.3
- 163 citationsRCR 33.1
- 145 citationsRCR 14.7
- Benmelstobart, anlotinib and chemotherapy in extensive-stage small-cell lung cancer: a randomized phase 3 trial.Nat Med · 2024145 citationsRCR 14.6
- Akkermansia muciniphila supplementation in patients with overweight/obese type 2 diabetes: Efficacy depends on its baseline levels in the gut.Cell Metab · 2025131 citationsRCR 35.4
- Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.N Engl J Med · 202499 citationsRCR 12.8
- Efficacy and Safety of Teprotumumab in Patients With Thyroid Eye Disease of Long Duration and Low Disease Activity.J Clin Endocrinol Metab · 202385 citationsRCR 13.7
- 83 citationsRCR 27.3
- 82 citationsRCR 27.2